• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Tuesday 10/23/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

CURE Pharmaceutical

  • 11:55 AM

    OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix Biosciences Ltd. (Nasdaq:TRPX), (“Therapix”), a specialty, clinical-stage pharmaceutical company developing cannabinoid-based treatments, to acquire the non-pain assets of Therapix, subject to the completion of the related conditions. These assets include several clinical drug candidates as well as two pre-clinical drug candidates. CURE will issue shares of its common stock to Therapix in exchange for

    Read more
  • 11:39 AM

    Results of In Vivo Study Signifies Completion of another Critical Milestone in Company’s Phase I of NIAID Contract* to Develop ODS Strip for Anti-Tuberculosis Treatment Option OXNARD, Calif., Oct. 03, 2017, CURR, (GLOBE NEWSWIRE) — Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed an in vivo study that compared the pharmacokinetics of its proprietary 300mg Isoniazid (INH) oral dissolvable strip (ODS) as an anti-tuberculosis (TB) treatment option against an existing

    Read more
  • 9:17 AM

    OXNARD, Calif., Jan. 24, 2017 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC Pink:CURR), a preeminent developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary, and buccal and dermal over-the-counter applications, today announces it has up listed from the OTC Pink exchange to the OTC QB. “We are pleased to have up listed our stock onto the OTC QB exchange,” said Rob Davidson, CEO of CURE Pharmaceutical. “We look forward to a continued productive relationship with OTC markets, and

    Read more
  • 9:47 AM

    Colorado Goldfields (PublicWire.com Press Release)Colorado Goldfields Inc. (OTCBB: CGFIA) announced today that in addition to the $6.1 million of preliminary purchase orders announced on Tuesday, June 22nd, the Company has received additional preliminary purchase orders totaling $3 million for custom gold ore milling from active mines in southwestern Colorado. Initial gold ore flow to Colorado Goldfields is now estimated to be approximately 300 tons per day by these orders, and represents $9.1 million in revenue in the first 12 months

    Read more
Public Wire Banner